X0508 4 2024-06-28 0001601485 Elicio Therapeutics, Inc. ELTX 0001413350 Venkatesan Jay C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501 BOSTON MA 02210 true false Common Warrants 5 2024-06-28 4 P 0 50000 0 A Common Stock 50000 50000 D Pre-Funded Warrants 0.01 2024-06-28 4 P 0 50000 4.99 A Common Stock 50000 50000 D Common Warrants 5 2024-06-28 4 P 0 50000 0 A Common Stock 50000 50000 I See footnote Pre-Funded Warrants 0.01 2024-06-28 4 P 0 50000 4.99 A Common Stock 50000 50000 I See footnote Common Warrants 5 2024-06-28 4 P 0 50000 0 A Common Stock 50000 50000 I See footnote Pre-Funded Warrants 0.01 2024-06-28 4 P 0 50000 4.99 A Common Stock 50000 50000 I See footnote Common Warrants 5 2024-06-28 4 P 0 50000 0 A Common Stock 50000 50000 I See footnote Pre-Funded Warrants 0.01 2024-06-28 4 P 0 50000 4.99 A Common Stock 50000 50000 I See footnote Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. The Common Warrants expire on July 1, 2029. Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. The Pre-Funded Warrants do not have an expiration date. The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any. /s/ Jay Venkatesan 2024-07-02